Life sciences firm HealthTell has raised $4m from private backers to bring to market a test kit for lung, breast, prostate, and colorectal cancer. The US-based firm, founded in 2010, is commercialising diagnostics technology originally developed at Arizona State University’s (ASU) Biodesign Institute. It is currently housed at the Innovations Incubator at Chandler, Arizona, where…
Arizona’s healthy $4m
Aug 21, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Feb 7, 2024
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024